Study of CS-3150 in Patients With Primary Aldosteronism

NCT02885662 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Aldosteronism

Interventions

DRUG: CS-3150

Sponsor

Daiichi Sankyo Co., Ltd.